COMMUNIQUÉS West-GlobeNewswire

Akari Therapeutics Receives FDA Fast Track Designation for Nomacopan for Pediatric Hematopoietic Stem Cell Transplant-Related Thrombotic Microangiopathy (HSCT-TMA)
14/08/2019
Fast Track designation by the U.S. Food and Drug Administration (FDA) facilitates the development and expedites the review of new medicines like nomacopan that treat serious unmet medical needs and in Akari’s case, [...]
Acasti Pharma Provides Business Update for the First Quarter of Fiscal 2020
14/08/2019
Achieved 100% Patient Randomization in both TRILOGY trials 68% of randomized patients have completed the studies On track to report topline results for TRILOGY 1 in December 2019 and TRILOGY 2 in January 2020 Fully [...]
Progyny Ranks #59 on the 2019 Inc. 5000
14/08/2019
The 38th annual list curates America’s fastest-growing private companies NEW YORK, Aug. 14, 2019 (GLOBE NEWSWIRE) -- Progyny, a leading fertility benefits management company, today announced that it was named #59 on Inc [...]
aTyr Pharma Announces Second Quarter 2019 Results and Provides Corporate Update
14/08/2019
aTyr to report interim safety results from Phase 1b/2a proof-of-concept trial of ATYR1923 in pulmonary sarcoidosis patients in Q4 2019 Company to host conference call and webcast today, August 14, at 5:00pm EDT SAN [...]
BrainsWay Ltd. to Host Second Quarter 2019 Financial Results Conference Call on August 26, 2019
14/08/2019
JERUSALEM and HACKENSACK, N.J., Aug. 14, 2019 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in the advanced non-invasive treatment of brain disorders, today [...]
Aleafia Health Reports Record Revenue in Q2 2019, 159% Q/Q Revenue Increase
14/08/2019
Q/Q sale of cannabis revenues increase 377% Q/Q gross profit increases to $2.9M from -$0.1M in previous quarter Q/Q expenses decrease 41% Adjusted EBITDA improves to loss of $2.7 million Strong balance sheet with $58M [...]
resTORbio Reports Second Quarter 2019 Financial Results and Corporate Update
14/08/2019
– Quarter highlighted by initiation and early completion of enrollment of Phase 3 PROTECTOR 1 trial; topline data expected by early first quarter of 2020 – BOSTON, Aug. 14, 2019 (GLOBE NEWSWIRE) -- resTORbio, Inc. ( [...]
Avenue Therapeutics Reports Second Quarter 2019 Financial Results and Recent Corporate Highlights
14/08/2019
NEW YORK, Aug. 14, 2019 (GLOBE NEWSWIRE) -- Avenue Therapeutics, Inc. (NASDAQ: ATXI) (“Avenue”), a company focused on the development of intravenous (“IV”) tramadol for the U.S. market, today reported financial results [...]
Scholar Rock Reports Second Quarter 2019 Financial Results and Highlights Business Progress
14/08/2019
Enrollment on track in the TOPAZ Phase 2 clinical trial of SRK-015 in patients with Type 2 and Type 3 Spinal Muscular Atrophy for preliminary PK/PD results by year-end Presented positive final results from the Phase 1 [...]
Italian Achromatopsia Association Increases Global Awareness of Achromatopsia, a Rare Genetic Eye Disease, With an Expedition to Pingelap, the Island of the Color Blind
14/08/2019
TRENTO, Italy, Aug. 14, 2019 (GLOBE NEWSWIRE) -- The Italian Achromatopsia Association (IAA) today announced that it is organizing a trip to Pingelap, a remote Micronesian atoll in the South Pacific, also known as the “ [...]
Auxly Announces Signing Of Term Sheet For $84 Million Credit Facilities Through Its Joint Venture Partner, Sunens Farms Inc.
14/08/2019
VANCOUVER, British Columbia, Aug. 14, 2019 (GLOBE NEWSWIRE) -- Auxly Cannabis Group Inc. (TSX.V - XLY) (" Auxly " or the " Company ") is pleased to announce that its joint venture partner, Sunens Farms Inc. (“ Sunens [...]
Onconova Therapeutics, Inc. Reports Business Highlights and Second Quarter 2019 Financial Results
14/08/2019
NEWTOWN, Pa., Aug. 14, 2019 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX) , a Phase 3 stage biopharmaceutical company discovering and developing novel products to treat cancer, with a focus on [...]
Solid Biosciences Reports Second Quarter 2019 Financial Results and Provides Business Update
14/08/2019
– Additional patient dosed at 2E14 vg/kg in second cohort of IGNITE DMD trial – – Study protocol amended to expedite clinical execution of SGT-001 – – Recent $60M capital raise extends runway into the fourth quarter of [...]
Ogilvy Health Further Cultivates Creative Community With Multiple Promotions
14/08/2019
PARSIPPANY, N.J., Aug. 14, 2019 (GLOBE NEWSWIRE) -- Ogilvy Health, part of Ogilvy ( www.ogilvy.com ), today announced the advancement of seven creative team members across the agency’s New Jersey and New York offices. [...]
Prevail Therapeutics Reports Second Quarter 2019 Financial Results and Recent Business Highlights
14/08/2019
IND Active for Phase 1/2 Trial of PR001 to Treat Parkinson’s Disease Patients with GBA1 Mutations Successful $125.0 Million Initial Public Offering Completed to Support Program Advancement and Expansion NEW YORK, Aug. [...]
PhaseBio Announces Receipt of Minutes of End-of-Phase 1 Meeting with the FDA and Alignment on a Single, Non-Randomized Phase 3 Trial to Support BLA Submission for PB2452
14/08/2019
Clinical development plan and Accelerated Approval regulatory path confirmed Phase 3 trial to initiate in the first quarter of 2020 and intended to support both major bleeding and surgery indications Conference call and [...]
Iterum Therapeutics Reports Second Quarter 2019 Financial Results
14/08/2019
--Phase 3 Topline Data anticipated in the fourth quarter-- -- NDA filings expected in first quarter of 2020-- DUBLIN, Ireland and CHICAGO, Aug. 14, 2019 (GLOBE NEWSWIRE) -- Iterum Therapeutics plc (Nasdaq: ITRM), a [...]
Adynxx Reports Second Quarter 2019 Financial Results
14/08/2019
SAN FRANCISCO, Aug. 14, 2019 (GLOBE NEWSWIRE) -- Adynxx, Inc. (OTCQB: ADYX), a clinical-stage biopharmaceutical company focused on the development of transcription factor decoy technology and first-in-class therapeutics [...]
JSC Olainfarm will add senior level management with international experience in pharmacy. Lauris Macijevskis continues to work on the Board of JSC Olainfarm
14/08/2019
In order to strengthen the management team of JSC Olainfarm, the Supervisory Council has decided to appoint a new candidate with international experience in pharmacy for the position of the Chairman of the Board of JSC [...]

Pages